Source: MarketScreener

Soligenix: Soligenix Announces Publication of Positive Pre-clinical Results for a Novel COVID-19 Vaccine

(marketscreener.com) PRINCETON, N.J., July 28, 2020 /PRNewswire/ -- Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today publication of pre-clinical immunogenicity studies for its CiVax program , demonstrating immunity...https://www.marketscreener.com/news/Soligenix-Announces-Publication-of-Positive-Pre-clinical-Results-for-a-Novel-COVID-19-Vaccine--31002766/?utm_medium=RSS&utm_content=20200728

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Christopher J. Schaber's photo - President & CEO of Soligenix

President & CEO

Christopher J. Schaber

CEO Approval Rating

68/100

Soligenix develops and commercializes biotherapeutics for the treatment of gastrointestinal disorders, inflammation and oncology diseases. Read more